Compare GILT & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GILT | EMBC |
|---|---|---|
| Founded | 1987 | 1924 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Radio And Television Broadcasting And Communications Equipment | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 756.1M | 719.7M |
| IPO Year | 1993 | N/A |
| Metric | GILT | EMBC |
|---|---|---|
| Price | $11.64 | $11.87 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 2 |
| Target Price | $16.00 | ★ $18.50 |
| AVG Volume (30 Days) | ★ 741.2K | 530.7K |
| Earning Date | 11-12-2025 | 11-25-2025 |
| Dividend Yield | N/A | ★ 4.95% |
| EPS Growth | ★ 42.22 | 20.90 |
| EPS | 0.41 | ★ 1.62 |
| Revenue | $392,826,000.00 | ★ $1,080,400,000.00 |
| Revenue This Year | $49.48 | $2.18 |
| Revenue Next Year | $13.61 | $0.54 |
| P/E Ratio | $28.69 | ★ $7.48 |
| Revenue Growth | ★ 29.68 | N/A |
| 52 Week Low | $5.30 | $9.20 |
| 52 Week High | $15.24 | $21.23 |
| Indicator | GILT | EMBC |
|---|---|---|
| Relative Strength Index (RSI) | 45.88 | 31.08 |
| Support Level | $11.25 | $12.10 |
| Resistance Level | $11.96 | $12.56 |
| Average True Range (ATR) | 0.45 | 0.74 |
| MACD | 0.06 | -0.26 |
| Stochastic Oscillator | 81.74 | 1.79 |
Gilat Satellite Networks Ltd is a provider of satellite-based broadband communications. The company designs and manufactures ground-based satellite communications equipment and provides comprehensive solutions and end-to-end services. Its portfolio includes a cloud-based satellite network platform, very small aperture terminals (VSATs), amplifiers, high-speed modems, on-the-move antennas and high-power solid-state power amplifiers (SSPAs), block-up converters (BUCs), and Transceivers. The company's solutions support multiple applications with a full portfolio of products to address key applications including broadband access, cellular backhaul, enterprise, in-flight connectivity, maritime, trains, defense, and public safety.
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.